Project description
Naturally controlled experiments may reveal novel disease predictors from infancy
The ‘Developmental Origins of Health and Disease’ (DOHaD) concept arose from findings more than 30 years ago that low birth weight is predictive of later risk for certain diseases. Since then, research has confirmed that our health and risk of disease throughout life are linked to conditions during the periconceptual period. This is relatively robust and repeatable across species although human studies are fewer given the practical difficulties of experimentation. DohART-NET is training a new cohort of DOHaD researchers through evaluation of links between parents’ periconceptual ‘environment’ (for example their health, chemical stressors or stress) and their babies’ health. The studies are strengthened by inclusion of so-called test-tube babies, one of the best-defined groups in this critical time period.
Objective
Altered conditions during the periconceptional (PC) period of gamete maturation and early embryonic development have long lasting effects on the health of the progeny, including the childhood, adolescent and adult-life onset of cardiovascular, metabolic and neurological diseases (‘Developmental Origins of Health and Disease (DOHaD) concept). Increasing evidence from epidemiological and animal model studies shows that children worldwide exhibit conditions and disease risks associated with the exposures of their parents, including chemical stressors before and during pregnancy, reproductive failure, adverse pregnancy outcome, diabetes, obesity and nutritional compromise. Babies born following human ART (“testtube”)interventions render this population (over 5 million world-wide) one of the largest well-defined clinical cohorts to be studied for a better understanding of the future risk of disease for current and succeeding generations in Europe. The DohART-NET project focus on the integration of pre-clinical (animal and stem cell-models) and clinical studies and apply data linkage, bioinformatics and network science for the identification and validation of mechanisms of diseases common in early development. We will exploit our new understanding to promote efficient disease prevention and potential personalised therapeutic interventions in both the general and ART populations to overcome adverse disease pathways. DohART-NET is optimized for training ESRs due to the facts that: i) the topic is progressive and much needed to improve public health over several generations, and it is integrating basic pre-clinical, translational clinical and in silico modeling approaches, iii) the partnership has a highly multi- and interdisciplinary scientific and training expertise and excellence, iv) there is an existing synergy by collaborations and links that the partners wish to strengthen both in science and lasting training programs in a highly inter-sectorial setting.
Fields of science
Keywords
Programme(s)
Coordinator
2100 Goedoello
Hungary
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participants (10)
CB2 1TN Cambridge
See on map
M13 9PL Manchester
See on map
SO17 1BJ Southampton
See on map
3015 GD Rotterdam
See on map
Participation ended
1090 Wien
See on map
80539 Muenchen
See on map
84184 Tiefenbach
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1050 Bruxelles / Brussel
See on map
46015 Valencia
See on map
1010 Wien
See on map
Partners (9)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
46010 Valencia
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1090 Wien
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
2100 Godollo
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
610065 CHENGDU
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
OX1 2JD Oxford
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1211 Geneve 6
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
EC2Y 5EB London
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1000 Bruxelles / Brussel
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
02453 Waltham Ma
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.